SynBioBeta

Subscribers Only

Access Now

Protera Strengthens Board with Appointment of Dr. Oswaldo da Costa e Silva as Non-Executive Director

Subscribers Only

Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production

Subscribers Only

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

Subscribers Only

Editas Medicine Announces The FDA Has Cleared Initiation Of The EDIT-301 Clinical Trial

Subscribers Only

Twist Bioscience to Expand Commercial Capabilities with Factory of the Future

Subscribers Only

LanzaTech and TeselaGen Biotechnology Sign New Multi-Year Deal to Advance Carbon Remediation via Biological Processes

Subscribers Only

Draper Signs Agreement with Kite to Accelerate Development of Cancer Immunotherapies

Subscribers Only

CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV

Subscribers Only

CATALOG Hires Key Scientists, Names Advisory Board to Advance DNA Computing and Storage

Subscribers Only

Intellia Therapeutics Announces Closing of $201 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Subscribers Only

Deepcell Closes $20 Million Series A Round to Develop AI-Powered Capture of Cells for Precision Medicine

Subscribers Only

Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Subscribers Only

Twist Bioscience Announces Pricing of a $300 Million Upsized Public Offering of Common Stock

Subscribers Only

Riffyn Selected as the Digital Backbone of BioMADE Network to Advance Domestic Biomanufacturing Innovation

Subscribers Only

Arzeda Expands Applications of its Protein Design Platform and Advances Towards Commercial Deployment of Designer Enzymes for Sustainable Food & Nutrition Ingredients

Subscribers Only

64x Bio Emerges from Stealth to Drive an Evolution in Cell and Gene Therapy Manufacturing

Subscribers Only

Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs

Subscribers Only

Twist Bioscience Expands Infectious Disease Product Line Adding Comprehensive Viral Panel

Subscribers Only

Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA

Subscribers Only

Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments

Ginkgo and Google Cloud Team Up to Supercharge Drug Development with New Protein LLM

Protera Strengthens Board with Appointment of Dr. Oswaldo da Costa e Silva as Non-Executive Director

Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

Editas Medicine Announces The FDA Has Cleared Initiation Of The EDIT-301 Clinical Trial

Twist Bioscience to Expand Commercial Capabilities with Factory of the Future

LanzaTech and TeselaGen Biotechnology Sign New Multi-Year Deal to Advance Carbon Remediation via Biological Processes

Draper Signs Agreement with Kite to Accelerate Development of Cancer Immunotherapies

CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV

CATALOG Hires Key Scientists, Names Advisory Board to Advance DNA Computing and Storage

Intellia Therapeutics Announces Closing of $201 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Deepcell Closes $20 Million Series A Round to Develop AI-Powered Capture of Cells for Precision Medicine

Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Twist Bioscience Announces Pricing of a $300 Million Upsized Public Offering of Common Stock

Riffyn Selected as the Digital Backbone of BioMADE Network to Advance Domestic Biomanufacturing Innovation

Arzeda Expands Applications of its Protein Design Platform and Advances Towards Commercial Deployment of Designer Enzymes for Sustainable Food & Nutrition Ingredients

64x Bio Emerges from Stealth to Drive an Evolution in Cell and Gene Therapy Manufacturing

Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs

Twist Bioscience Expands Infectious Disease Product Line Adding Comprehensive Viral Panel

Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA

Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments